Jorquera Patricia A, Anderson Lydia, Tripp Ralph A
Department of Infectious Diseases, College of Veterinary Medicine, Animal Health Research Center, University of Georgia, 111 Carlton Street, Athens, GA, 30602, USA.
Methods Mol Biol. 2016;1442:1-12. doi: 10.1007/978-1-4939-3687-8_1.
Human respiratory syncytial virus (RSV) is understood to be a significant human pathogen in infants, young children, and the elderly and the immunocompromised. Over the last decade many important mechanisms contributing to RSV infection, replication, and disease pathogenesis have been revealed; however, there is still insufficient knowledge which has in part hampered vaccine development. Considerable information is accumulating regarding how RSV proteins modulate molecular signaling and immune responses to infection. Understanding how RSV interacts with its host is crucial to facilitate the development of safe and effective vaccines and therapeutic treatments.In this chapter, we provide a brief introduction into RSV replication, pathogenesis, and host immune response, and summarize the state of RSV vaccine and antiviral compounds in clinical stages of development. This chapter frames features of this book and the molecular methods used for understanding RSV interaction with the host.
人呼吸道合胞病毒(RSV)被认为是婴幼儿、老年人以及免疫功能低下者的一种重要人类病原体。在过去十年中,许多导致RSV感染、复制及疾病发病机制的重要机制已被揭示;然而,仍存在知识不足的情况,这在一定程度上阻碍了疫苗的研发。关于RSV蛋白如何调节分子信号传导以及对感染的免疫反应,已有大量信息不断积累。了解RSV如何与宿主相互作用对于促进安全有效的疫苗和治疗方法的开发至关重要。在本章中,我们简要介绍RSV的复制、发病机制和宿主免疫反应,并总结处于临床开发阶段的RSV疫苗和抗病毒化合物的情况。本章勾勒了本书的特点以及用于理解RSV与宿主相互作用的分子方法。